Diagnosi e Cura delle Cefalee-‐2009
Transcription
Diagnosi e Cura delle Cefalee-‐2009
Diagnosi e Cura delle Cefalee-‐2009 TREATMENT OPTION SYMPTOMATIC PROPHYLACTIC There is no evidence that medications effective in adults are safe and effective in younger patients Treatment of migraine “Placebo responders” Treatment Children Prophylactic 16 – 55% (a) 14 – 34% (a) Symptomatic 20 – 69% (b,) 6 – 44% (a) a) Van der Kuy 2002 b) Ueberall 1999 – Winner 2000 Aaltonen 2000 – Visser 2004 Adults Diagnosi e Cura delle Cefalee-‐2009 Diagnosi e Cura delle Cefalee-‐2009 ADVANCES IN ACUTE MIGRAINE TREATMENT IN CHILDREN AND ADOLESCENTS Diagnosi e Cura delle Cefalee-‐2009 Two triptans are now FDA-‐approved for pediatric use for acute migraine: Almotriptan is approved in adolescents’ ages 12–17 years. The 2-‐h pain relief rate was 71.8% for a 6.25mg dose, and 72.9% for the 12.5mg dose. (Linder 2008) Rizatriptan was recently approved for 6–17 year olds. The 2-‐h pain relief rate was 73–74%. The approved dosing is 5mg in those less than 40 kg, and 10mg for those at least 40 kg . (Ahonen 2006) Diagnosi e Cura delle Cefalee-‐2009 Diagnosi e Cura delle Cefalee-‐2009 SUMATRIPTAN + NAPROXEN Diagnosi e Cura delle Cefalee-‐2009 EMERGENCY ROOM SETTING Diagnosi e Cura delle Cefalee-‐2009 EMERGENCY ROOM SETTING Diagnosi e Cura delle Cefalee-‐2009 No OPIOIDS! TREATMENTS SYMPTOMATIC PROPHYLACTIC Diagnosi e Cura delle Cefalee-‐2009 1. 2. 3. 4. 5. frequency is ≥ 4/month attacks duration is ≥ 4 hours pain is moderate-severe ineffective symptomatic drugs symptomatic drugs’ side effects TREATMENT OPTIONS PHARMACHOLOGICAL NON PHARMACHOLOGICAL Diagnosi e Cura delle Cefalee-‐2009 are effective and should be considered in children and adolescents are effective and should be considered in adolescents (Riza also in children >6yrs) insufficient data are currently available to recommend their use both in children and adolescents Prophylactic drug treatment probably effective efficacy data are conflicting insufficient evidence to make any recommendations Tension-type headache pharmacologic treatment in childhood and adolescents is completely unexplored Conclusions There is a clear and urgent need for controlled, randomized and masked trials ≠ The complexity of headache (biological, psychological and environmental factors) Socrate was used to say his friend Carmide, suffering from recurrent headache: “Do not permit somebody to take care of your head without offering you the opportunity to dress your soul by means of delicate and profound conversations” Platone “I dialoghi dell’amore”